CN108157911A - A kind of purple perilla salt and preparation method thereof - Google Patents
A kind of purple perilla salt and preparation method thereof Download PDFInfo
- Publication number
- CN108157911A CN108157911A CN201711450528.9A CN201711450528A CN108157911A CN 108157911 A CN108157911 A CN 108157911A CN 201711450528 A CN201711450528 A CN 201711450528A CN 108157911 A CN108157911 A CN 108157911A
- Authority
- CN
- China
- Prior art keywords
- salt
- perilla
- purple perilla
- vitamin
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 53
- 235000004347 Perilla Nutrition 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims description 12
- 244000124853 Perilla frutescens Species 0.000 title 1
- 241000229722 Perilla <angiosperm> Species 0.000 claims abstract description 52
- 150000001413 amino acids Chemical class 0.000 claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 10
- 239000011707 mineral Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 229940088594 vitamin Drugs 0.000 claims abstract description 9
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 9
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 9
- 235000010755 mineral Nutrition 0.000 claims description 9
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- 238000005538 encapsulation Methods 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000004475 Arginine Substances 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000004474 valine Substances 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- 229940045997 vitamin a Drugs 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 4
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 4
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 4
- 229960002733 gamolenic acid Drugs 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 235000019156 vitamin B Nutrition 0.000 claims description 3
- 239000011720 vitamin B Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- 229930003270 Vitamin B Natural products 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- NDTYTMIUWGWIMO-UHFFFAOYSA-N perillyl alcohol Chemical compound CC(=C)C1CCC(CO)=CC1 NDTYTMIUWGWIMO-UHFFFAOYSA-N 0.000 abstract description 34
- 230000001093 anti-cancer Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 235000002639 sodium chloride Nutrition 0.000 description 39
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- CDSMSBUVCWHORP-UHFFFAOYSA-N perillic acid Chemical compound CC(=C)C1CCC(C(O)=O)=CC1 CDSMSBUVCWHORP-UHFFFAOYSA-N 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides a kind of purple perilla salt, which is made of the raw material for including following parts by weight:90 97 parts of salt, 15 parts of perilla alcohol, 15 parts of perilla herb oil, 0.5 2 parts of amino acid, 0.1 0.5 parts of polyunsaturated fatty acid, 0.02 0.1 parts of vitamin, 0.2 1 parts of minerals.Salt and perilla herb oil, perilla alcohol are combined by purple perilla salt of the present invention, and by diet, perilla herb oil, perilla alcohol are absorbed, and have effects that anticancer, anti-aging.
Description
Technical field
The invention belongs to functional common salt field, more particularly, to a kind of purple perilla salt and preparation method thereof.
Background technology
Salt is essential flavouring in people's life, it has inseparable substantial connection with health.
The study found that salt is good carrier again, the amino acid of certain amount and ratio, vitamin B complex, polysaccharide are added in salt
And chitin, hypertension that minerals and trace element etc. persistently increase current incidence, diabetes, cancer, hyperlipidemia, hat
The diseases such as worry, nephrosis, apoplexy and cardiovascular and cerebrovascular disease, osteoporosis, cataract, skin disease have good preventive effect.
Perilla alcohol can inhibit tumour, and reverse has formed tumour.Tumour forms initial rank, can not only reduce tumour
Probability, moreover it is possible to reduce tumour species survey, also have to reverse to established breast cancer, cancer of pancreas, prostate cancer, liver cancer etc. and make
With.Oral 10min can detect perillic acid and dehydration perillic acid rather than perilla alcohol in its serum, and it is logical in vivo to prompt it
It crosses metabolite and plays antitumaous effect.
From the dry fruit of labiate purple perilla maturation or purple perilla plant, extraction is obtained to contain a- for Purple Perilla Seed Oil system
The multi-component mixture such as leukotrienes is a kind of high-quality edible health-care oil wherein without harmful components such as erucic acid, have reducing blood lipid,
Improve the effect of memory, anti-aging, antiallergy, anticancer.
And the product for not in the market being combined perilla alcohol, perilla herb oil and salt.
Invention content
In view of this, the present invention is directed to propose a kind of purple perilla salt and preparation method thereof, purple perilla salt have anticancer, it is anti-oxidant,
Antianaphylactic effect.
In order to achieve the above objectives, the technical proposal of the invention is realized in this way:
A kind of purple perilla salt, the purple perilla salt are made of the raw material for including following parts by weight:
Preferably, the purple perilla salt is made of the raw material for including following parts by weight:
Further, the amino acid is at least one of valine, arginine or glutamine.
Further, the polyunsaturated fatty acid is one kind in alpha-linolenic acid or gamma-Linolenic acid.
Further, the vitamin is at least one of vitamin A, vitamin B, vitamin C or vitamin E.
Further, the minerals are at least one of calcium, iron, zinc or magnesium.
The preparation method of the purple perilla salt, includes the following steps:By perilla alcohol, amino acid, vitamin, minerals with it is more
Unrighted acid is uniformly dissolved in the perilla herb oil, the mixture is wrapped in by micro-encapsulation technology described
Salt surface to get.
Relative to the prior art, purple perilla salt of the present invention and preparation method thereof has the advantage that:
Salt and perilla herb oil, perilla alcohol are combined by purple perilla salt of the present invention, by diet, to purple perilla
Oil, perilla alcohol are absorbed, and have effects that anticancer, anti-aging.
The preparation method of purple perilla salt of the present invention uses micro-encapsulation technology, can material effectively be wrapped in salt
The outside of particle ensure that the absorption of nutritional ingredient.
Specific embodiment
In addition to being defined, technical term used in following embodiment has universal with those skilled in the art of the invention
The identical meanings of understanding.Test reagent used in following embodiment is conventional biochemical reagent unless otherwise specified;It is described
Experimental method is conventional method unless otherwise specified.
With reference to embodiment, the present invention will be described in detail.
Embodiment 1
A kind of purple perilla salt, the purple perilla salt are made of the raw material for including following parts by weight:92 parts of salt, 2 parts of perilla alcohol, purple perilla
2 parts of oil, 0.2 part of valine, 0.2 part of arginine, 0.2 part of glutamine, 0.1 part of alpha-linolenic acid, 0.01 part of vitamin A, dimension life
Plain 0.01 part of B, 0.01 part of vitamin C, 0.1 part of calcium, 0.1 part of iron.
The preparation method of the purple perilla salt, includes the following steps:By perilla alcohol, amino acid, vitamin, minerals with it is more
Unrighted acid is uniformly dissolved in the perilla herb oil, the mixture is wrapped in by micro-encapsulation technology described
Salt surface to get.
Embodiment 2
A kind of purple perilla salt, the purple perilla salt are made of the raw material for including following parts by weight:97 parts of salt, 3 parts of perilla alcohol, purple perilla
1 part of oil, 0.2 part of valine, 0.2 part of arginine, 0.2 part of glutamine, 0.1 part of alpha-linolenic acid, 0.01 part of vitamin A, dimension life
Plain 0.01 part of B, 0.01 part of vitamin C, 0.1 part of calcium, 0.1 part of iron.
The preparation method of the purple perilla salt, includes the following steps:By perilla alcohol, amino acid, vitamin, minerals with it is more
Unrighted acid is uniformly dissolved in the perilla herb oil, the mixture is wrapped in by micro-encapsulation technology described
Salt surface to get.
Embodiment 3
A kind of purple perilla salt, the purple perilla salt are made of the raw material for including following parts by weight:95 parts of salt, 2 parts of perilla alcohol, purple perilla
2 parts of oil, 0.2 part of valine, 0.2 part of arginine, 0.2 part of glutamine, 0.1 part of gamma-Linolenic acid, 0.01 part of vitamin A, dimension
Raw 0.01 part of element B, 0.01 part of vitamin C, 0.1 part of calcium, 0.1 part of iron.
The preparation method of the purple perilla salt, includes the following steps:By perilla alcohol, amino acid, vitamin, minerals with it is more
Unrighted acid is uniformly dissolved in the perilla herb oil, the mixture is wrapped in by micro-encapsulation technology described
Salt surface to get.
Embodiment 4
A kind of purple perilla salt, the purple perilla salt are made of the raw material for including following parts by weight:97 parts of salt, 3 parts of perilla alcohol, purple perilla
1 part of oil, 0.2 part of valine, 0.2 part of arginine, 0.2 part of glutamine, 0.1 part of gamma-Linolenic acid, 0.01 part of vitamin A, dimension
Raw 0.01 part of element B, 0.01 part of vitamin D, 0.1 part of calcium, 0.1 part of magnesium.
The preparation method of the purple perilla salt, includes the following steps:By perilla alcohol, amino acid, vitamin, minerals with it is more
Unrighted acid is uniformly dissolved in the perilla herb oil, the mixture is wrapped in by micro-encapsulation technology described
Salt surface to get.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention
With within principle, any modification, equivalent replacement, improvement and so on should all be included in the protection scope of the present invention god.
Claims (7)
1. a kind of purple perilla salt, it is characterised in that:The purple perilla salt is made of the raw material for including following parts by weight:
2. purple perilla salt according to claim 1, it is characterised in that:The purple perilla salt is by including the raw materials of following parts by weight
It is made:
3. purple perilla salt according to claim 2, it is characterised in that:The amino acid is valine, arginine or paddy ammonia
At least one of amide.
4. purple perilla salt according to claim 2, it is characterised in that:The polyunsaturated fatty acid for alpha-linolenic acid or
One kind in gamma-Linolenic acid.
5. purple perilla salt according to claim 2, it is characterised in that:The vitamin is vitamin A, vitamin B, dimension are given birth to
At least one of plain C or vitamin E.
6. purple perilla salt according to claim 2, it is characterised in that:The minerals be calcium, iron, zinc or magnesium at least
It is a kind of.
7. the preparation method of the purple perilla salt described in any one of claim 1-6, it is characterised in that:Include the following steps:It will be purple
Soviet Union's alcohol, amino acid, vitamin, minerals and polyunsaturated fatty acid are uniformly dissolved in the perilla herb oil, and described is mixed
Close object be wrapped in by micro-encapsulation technology the surface of the salt to get.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711450528.9A CN108157911A (en) | 2017-12-27 | 2017-12-27 | A kind of purple perilla salt and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711450528.9A CN108157911A (en) | 2017-12-27 | 2017-12-27 | A kind of purple perilla salt and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108157911A true CN108157911A (en) | 2018-06-15 |
Family
ID=62518684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711450528.9A Pending CN108157911A (en) | 2017-12-27 | 2017-12-27 | A kind of purple perilla salt and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108157911A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109156796A (en) * | 2018-09-04 | 2019-01-08 | 河北三匠园生物科技发展有限公司 | The purple perilla edible salt and preparation method thereof eaten suitable for hyperlipemic patients |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1107666A (en) * | 1994-03-17 | 1995-09-06 | 王跃进 | Health edible salt |
CN2223007Y (en) * | 1995-06-01 | 1996-03-27 | 王跃进 | Metered nutrient filling salt |
CN1387794A (en) * | 2002-07-08 | 2003-01-01 | 岳静 | Health table salt |
CN101049150A (en) * | 2006-07-25 | 2007-10-10 | 陈治先 | Edible nourishment health care potassium salt with extensive use |
CN105285901A (en) * | 2015-09-20 | 2016-02-03 | 中盐榆林盐化有限公司 | DHA edible salt and preparation method thereof |
CN105962286A (en) * | 2016-05-03 | 2016-09-28 | 王胜 | Plant salt containing lavandulaangustifoliamill extract and preparation method of plant salt |
CN106174402A (en) * | 2016-07-20 | 2016-12-07 | 李新民 | A kind of full nutritive element health-care salt and preparation method thereof |
-
2017
- 2017-12-27 CN CN201711450528.9A patent/CN108157911A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1107666A (en) * | 1994-03-17 | 1995-09-06 | 王跃进 | Health edible salt |
CN2223007Y (en) * | 1995-06-01 | 1996-03-27 | 王跃进 | Metered nutrient filling salt |
CN1387794A (en) * | 2002-07-08 | 2003-01-01 | 岳静 | Health table salt |
CN101049150A (en) * | 2006-07-25 | 2007-10-10 | 陈治先 | Edible nourishment health care potassium salt with extensive use |
CN105285901A (en) * | 2015-09-20 | 2016-02-03 | 中盐榆林盐化有限公司 | DHA edible salt and preparation method thereof |
CN105962286A (en) * | 2016-05-03 | 2016-09-28 | 王胜 | Plant salt containing lavandulaangustifoliamill extract and preparation method of plant salt |
CN106174402A (en) * | 2016-07-20 | 2016-12-07 | 李新民 | A kind of full nutritive element health-care salt and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109156796A (en) * | 2018-09-04 | 2019-01-08 | 河北三匠园生物科技发展有限公司 | The purple perilla edible salt and preparation method thereof eaten suitable for hyperlipemic patients |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Taboada et al. | Nutritional value of the marine algae wakame (Undaria pinnatifida) and nori (Porphyra purpurea) as food supplements | |
CN104892062A (en) | A nanometer selenium nutritive liquid fertilizer and applications | |
Patil et al. | Lipids and fatty acid profiling of major Indian Garcinia fruit: A comparative study and its nutritional impact | |
Panaite et al. | Flaxseeds: nutritional potential and bioactive compounds | |
Muthu et al. | Proximate and mineral compositions of edible mushroom Agrocybe aegerita | |
CN104206710B (en) | Traditional Chinese medicinal feed additive containing N-carbamylglutamic acid, and its application | |
CN108041555A (en) | A kind of stem of noble dendrobium salt and preparation method thereof | |
CN108157911A (en) | A kind of purple perilla salt and preparation method thereof | |
CN105124215A (en) | Traditional Chinese medicine containing meat sheep concentrated feed | |
AÇIKGÖZ et al. | CHEMICAL COMPOSITION OF TURKISH OKRA SEEDS (Hibiscus esculenta L.) AND THE TOTAL PHENOLIC CONTENT OF OKRA SEEDS FLOUR. | |
CN108402439A (en) | A kind of alpha-linolenic acid salt and preparation method thereof | |
EP2705761B1 (en) | Nutritional composition for pregnant women | |
Yasmeen et al. | Formulation and biochemical evaluation of designer diet enriched with botanicals for bone health | |
Konan et al. | Phytochemical, nutritional and antioxidant capacity of five Ivorian edible leaves aqueous extracts | |
Ilias et al. | Rice bran of different rice varieties in Malaysia: Analysis of proximate compositions, antioxidative properties and fatty acid profile for data compilation | |
Oyetayo | Mineral element enrichment of mushrooms for the production of more effective functional foods | |
Wojcieszek et al. | Study of bioaccessibility of cobalt species in berries and seeds by mass spectrometry techniques | |
El Hawary et al. | Study of nutritional contents of Prunus amygdalus Batsch seeds | |
CN108378344A (en) | A kind of intelligence development salt and preparation method thereof | |
CN108157913A (en) | A kind of Jin Weita salt and preparation method thereof | |
Notova et al. | Change of elemental composition in muscular tissue and hair under food stress | |
Adebiyi et al. | Comparative studies on the proximate compositions, minerals and anti-nutritional factors in the leaves and stem of Grewia carpinifolia | |
US20200337335A1 (en) | Novel palatable pet food composition | |
GR et al. | NEUTRACUETICAL EVALUATION OF BOERHAVIA DIFFUSA L. | |
Chedea et al. | Evaluation of camelina meal as a dietary source of polyphenol for dairy cows. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180615 |
|
RJ01 | Rejection of invention patent application after publication |